Recombinant Human Apo-Serum Amyloid A (Apo-SAA) (A118-1mg)

Apolipoprotein Serum Amyloid A (Apo-SAA) is a highly conserved acute-phase apolipoprotein that circulates in trace amounts in healthy human serum but can increase up to 1000-fold during acute and chronic inflammatory responses such as infection, trauma, cancer, and infarction. Acting as a major component of high-density lipoprotein (HDL) during inflammation, Apo-SAA replaces Apo-AI and remodels HDL particles, making them larger and denser. This acute-phase protein plays critical roles in modulating immune responses, lipid metabolism, and amyloid fibril formation as the precursor to amyloid A protein. Apo-SAA is an important biomarker for inflammation, metabolic disorders, and amyloidosis, and its recombinant form is widely used in research focusing on inflammatory pathways, cardiovascular disease, and immune regulation. This recombinant human Apo-SAA protein is purified to >98% purity and is ideal for in vitro applications investigating the molecular mechanisms of inflammation and related diseases.